In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback